To include your compound in the COVID-19 Resource Center, submit it here.

DNA beats Street EPS estimate

Genentech (DNA) reported after market close 2001 EPS of $0.76, a penny better than the Street's

Read the full 160 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE